z-logo
Premium
IgG2b Inducing Factor from Rheumatoid Arthritis Synovial Fluid Synergizes with Transforming Growth Factor‐β in Promoting IgG2b Antibody Production in Mouse B Lymphocytes
Author(s) -
LETTESJO¨ H.,
RIDDERSTAD A.,
MO¨LLER E.
Publication year - 1997
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1046/j.1365-3083.1997.d01-372.x
Subject(s) - antibody , immunology , synovial fluid , transforming growth factor , microbiology and biotechnology , rheumatoid factor , transforming growth factor beta , arthritis , biology , medicine , endocrinology , pathology , alternative medicine , osteoarthritis
Rheumatoid arthritis synovial fluid (RA‐SF) contains a distinct biological activity that selectively induces IgG2b production in LPS‐activated murine B blasts. This IgG2b inducing factor (IgG2bIF) acts directly on purified LPS‐activated B blasts from normal and Bruton's tyrosine kinase‐defective CBA/N mice. In order to test the possibility that TGF‐β and IgG2bIF in RA‐SF act in concert to induce IgG2b production, anti‐TGF‐β monoclonal antibodies and RA‐SF were added to LPS‐activated CBA B blasts, which led to a marked reduction of IgG2b‐producing cells. This result indicates that TGF‐β and IgG2bIF in RA‐SF synergize in the induction of IgG2b production. TGF‐β antibodies do not inhibit IgG2b production in CBA/N B blasts, further substantiating our earlier notion that CBA/N B blasts have a higher endogenous production of TGF‐β after LPS stimulation, which might be responsible for the aberrant reactivity in btk deficient CBA/N mice. RA‐SF is able to reconstitute the deficient IgG1 response in LPS‐ and IL‐4‐stimulated CBA/N B blasts. Addition of antibodies against TGF‐β had only a marginal effect on the IgG1 response, indicating that the reconstitution is mediated by another factor(s), which is present in RA‐SF.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here